Abstract
A 44-year-old man suffering from cytogenetically and molecularly proven Philadelphia translocation-positive chronic myelogenous leukemia in chronic phase was treated with busulfan for 18 months and studied during a follow-up period of 13 years. Hematologically and cytogenetically, he attained a continuing complete remission, although at one point (9.5 years) at least, after attaining complete remission molecular analysis indicated the presence of minimal residual disease.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 27 October 1995 / Accepted: 27 February 1996
Rights and permissions
About this article
Cite this article
Mandigers, C., Mensink, E., van Kessel, A. et al. A long-lasting, complete hematologic and cytogenetic remission of chronic myelogenous leukemia after treatment with busulfan alone. Ann Hematol 72, 371–373 (1996). https://doi.org/10.1007/s002770050188
Issue Date:
DOI: https://doi.org/10.1007/s002770050188